First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Can exercise or ibuprofen fight chemo brain? April 23, 2026 Democratic hopefuls fault GOP incumbents for anti-abortion records in Congress September 27, 2024 UCL research reveals anxiety as a major risk factor for Parkinson’s June 24, 2024